News

A common diabetes drug can reduce the pain of people with knee osteoarthritis and overweight or obesity, possibly delaying ...
II, a non-opioid treatment for knee osteoarthritis. Published in Osteoarthritis and Cartilage journal, the study reveals that ...
Indias Sun Pharma and Israels Moebius Medical published new data on MM-II, a non-opioid treatment for knee osteoarthritis.
A common diabetes drug can reduce the pain of people with knee osteoarthritis and overweight or obesity, possibly delaying the need for knee replacements, Monash University-led research has found.
The diabetes drug metformin provided overweight/obese patients with osteoarthritis (OA) of the knee with significantly ...
A common diabetes drug can reduce the pain of people with knee osteoarthritis and overweight or obesity, possibly delaying the need for knee ...
A new study has uncovered another benefit of one of the country's most commonly prescribed medications for diabetes - joint ...
Eupraxia's CEO, Dr. James Helliwell, will be presenting on May 5th, 2025, at 3:30pm ET at the Bloom Burton & Co. Healthcare Investor Conference being held at the Metro Toronto Convention Centre, and ...
I’ve been a runner—on and off—for over 25 years. For years, my goal was qualifying for the Boston Marathon. But I was never quite fast enough for my age group. At one point, I figured if I cou ...
The results of this randomized clinical trial support use of metformin for treatment of symptomatic knee osteoarthritis in people ...